Delirium – triggers and treatments
Delirium can affect up to 70 percent of patients in intensive care units (ICUs) and in other acute care settings; it is a condition that can have far-reaching […]
Delirium can affect up to 70 percent of patients in intensive care units (ICUs) and in other acute care settings; it is a condition that can have far-reaching […]
Dr Cathrine McKenzie, Senior Pharmacist, Critical Care argues that pharmacists in all sectors need to be aware of delirium because they all have something to contribute. Moreover, a […]
The number of pharmacotherapies for delirium is “disappointingly low”, but a number of other measures can help and research into new and repurposed treatments is under way, says […]
There are numerous risk factors for delirium including old age, severe infections, ischaemic heart disease and the anticholinergic burden of drug therapy, according to Dr Cathrine McKenzie, Senior […]
Delirium can affect up to 70 percent of patients in intensive care and is a condition that can have far-reaching consequences. IMI spoke to Dr Cathrine McKenzie, Senior […]
Despite considerable advances in the understanding of asthma and the treatments available, at least three deaths each day in the UK are due to asthma. In this series […]
Pharmacists bring a special and distinctive set of skills to the care of people with asthma and it is an area that can offer a stimulating and rewarding […]
Steroid stewardship is an important task for respiratory pharmacists and is one of the measures that can have a positive impact on the overall outcomes of asthma explains […]
There are numerous opportunities for pharmacists to work in respiratory medicine across the whole spectrum of health care in a variety of roles, according to Dr Anna Murphy, […]
As an independent prescriber Dr Anna Murphy, Consultant Respiratory Pharmacist, keenly aware that she is accountable for what she prescribes. Here, she describes how she uses her pharmaceutical […]
Three deaths each day in the UK are due to asthma despite considerable advances in the understanding of the disease and the treatments available. IMI spoke to Dr […]
Professor Gino Martini was recently appointed as the Chief Executive of the Precision Health Technologies Accelerator (PHTA) at Birmingham University. Previously he was Chief Scientist at the Royal […]